Similar articles

• Chronic viral hepatitis.

  Garcia G, Gentry KR. Garcia G, et al. Med Clin North Am. 1989 Jul;73(4):971-83. doi: 10.1016/s0025-7125(16)30648-4. Med Clin North Am. 1989. PMID: 2471027 Review.
• [Treatment of chronic viral hepatitis].

  Ferraz ML, Lopes EP, Adania RS, de Oliveira PM, Silva AE, Guimarães RX. Ferraz ML, et al. Rev Assoc Med Bras (1992). 1993 Apr-Jun;39(2):107-14. Rev Assoc Med Bras (1992). 1993. PMID: 7694730 Review. Portuguese. No abstract available.
• Approaches to the treatment of hepatitis B virus and delta-related liver disease.

  Thomas HC, Lever AM, Scully LJ, Pignatelli M. Thomas HC, et al. Semin Liver Dis. 1986 Feb;6(1):34-41. doi: 10.1055/s-2008-1040791. Semin Liver Dis. 1986. PMID: 2424091 Review. No abstract available.
• [The goals of therapy].

  Saracco G. Saracco G. Minerva Gastroenterol Dietol. 1995 Mar;41(1):77-9. Minerva Gastroenterol Dietol. 1995. PMID: 7542486 Review. Italian. No abstract available.
• Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection.

  Trépo C, Ouzan D, Fontanges T, Chevallier M, Chossegros P, Degos F, Chevallier P, Hantz O. Trépo C, et al. J Hepatol. 1986;3 Suppl 2:S129-35. doi: 10.1016/s0168-8278(86)80111-8. J Hepatol. 1986. PMID: 2439569